These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17569198)

  • 21. Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23).
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2010 Jul; 126(1):186-90. PubMed ID: 20498180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 13-valent pneumococcal vaccine: 50 years of age and older.
    Prescrire Int; 2013 Feb; 22(135):38. PubMed ID: 23444498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults.
    Durando P; Faust SN; Fletcher M; Krizova P; Torres A; Welte T
    Clin Microbiol Infect; 2013 Oct; 19 Suppl 1():1-9. PubMed ID: 24083785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. US study suggests universal vaccination of children with pneumococcal conjugate vaccine is beneficial for adults.
    Doroshenko A
    Euro Surveill; 2005 Nov; 10(11):E051124.4. PubMed ID: 16794287
    [No Abstract]   [Full Text] [Related]  

  • 25. Recent Developments and Future Directions of Pneumococcal Vaccine Recommendations.
    Tromp KM; Campbell MW; Vazquez A
    Clin Ther; 2015 May; 37(5):928-34. PubMed ID: 25913921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations.
    Butler JC; Breiman RF; Campbell JF; Lipman HB; Broome CV; Facklam RR
    JAMA; 1993 Oct; 270(15):1826-31. PubMed ID: 8411526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do your part to stave off STREP.
    Schweon SJ
    RN; 2005 Oct; 68(10):34-8; quiz 39. PubMed ID: 16259184
    [No Abstract]   [Full Text] [Related]  

  • 28. Pneumococcal conjugate vaccine for young children.
    Zimmerman RK
    Am Fam Physician; 2001 May; 63(10):1991-8. PubMed ID: 11388715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pneumococcal vaccination in people living with HIV.
    Thornhill J; Sivaramakrishnan A; Orkin C
    Vaccine; 2015 Jun; 33(28):3159-60. PubMed ID: 25128803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(36):893-7. PubMed ID: 16163262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Recommendations for prevention of community-acquired pneumonia with bacteremia as the leading form of invasive pneumococcal infections in the population of people over 50 years of age and risk groups above 19 years of age].
    Albrecht P; Antczak A; Hryniewicz W; Skoczyńska A; Radzikowski A; Kedziora-Kornatowska K; Bernatowska E; Stompór T; Grodzicki T; Gyrczuk E; Imiela J; Jedrzejczak W; Windak A
    Pol Merkur Lekarski; 2014 Feb; 36(212):79-87. PubMed ID: 24720101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23).
    ;
    MMWR Morb Mortal Wkly Rep; 2010 Sep; 59(34):1102-6. PubMed ID: 20814406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine.
    Lexau CA; Lynfield R; Danila R; Pilishvili T; Facklam R; Farley MM; Harrison LH; Schaffner W; Reingold A; Bennett NM; Hadler J; Cieslak PR; Whitney CG;
    JAMA; 2005 Oct; 294(16):2043-51. PubMed ID: 16249418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old--Taiwan's PPV vaccination program.
    Tsai YH; Hsieh MJ; Chang CJ; Wen YW; Hu HC; Chao YN; Huang YC; Yang CT; Huang CC
    Vaccine; 2015 Jun; 33(25):2897-902. PubMed ID: 25936662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in pneumococcal vaccines: what are the advantages for the elderly?
    Vila-Córcoles A
    Drugs Aging; 2007; 24(10):791-800. PubMed ID: 17896829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of a guideline-based best practice alert on pneumococcal vaccination rates in adults in a primary care setting.
    McAdam-Marx C; Tak C; Petigara T; Jones NW; Yoo M; Briley MS; Gunning K; Gren L
    BMC Health Serv Res; 2019 Jul; 19(1):474. PubMed ID: 31291959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What do we know about the cost-effectiveness of pneumococcal conjugate vaccination in older adults?
    Newall AT
    Hum Vaccin Immunother; 2016 Oct; 12(10):2666-2669. PubMed ID: 27398741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time for changes in pneumococcal vaccination of adults?
    Overman MC
    J Am Osteopath Assoc; 2011 Oct; 111(10 Suppl 6):S19-22. PubMed ID: 22086890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Why the recent ACIP recommendations regarding conjugate pneumococcal vaccine in adults may be irrelevant.
    Musher DM; Rodriguez-Barradas MB
    Hum Vaccin Immunother; 2016; 12(2):331-5. PubMed ID: 26606172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Navigating pneumococcal vaccination in adults.
    Pallotta A; Rehm SJ
    Cleve Clin J Med; 2016 Jun; 83(6):427-33. PubMed ID: 27281256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.